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A 74-year-old woman was admitted in an hospital because of abnormal lung shadow in chest X–P.
Imaging modalities including CT, MRI, and PET demonstrated a small (12 mm in diameter) mass in the
periphery of the right upper lobe. Although biopsy and cytology were negative, wedge resection was
performed. Grossly, the lesion was a round white tumor measuring 10  10  9 mm located beneath the
pleura. Microscopically, the tumor consisted of proliferation of atypical spindle cells with hyperchromatic
nuclei. The tumor cells were continuous with bronchial smooth muscle. Mitotic ﬁgures were recognized
in 20 per 10 high power ﬁelds. There were foci of necrosis and deposition of dusts and hemosiderin.
Residual bronchi were present within the tumor. Immunohistochemically, the tumor cells were positive
for vimentin, a-smooth muscle actin, caldesmon, and Ki-67 (labeling ¼ 50%), but negative for cytoker-
atins (AE1/3, CAM5.2, KL-1, and polyclonal wide), cytokeratin 5/6, cytokeratin 7, cytokeratin 20, epithelial
membrane antigen, melanosome, TTF-1, desmin, CD34, calreninin, D2-40 (podoplanin), S100 protein,
p53 protein, myoglobin, KIT, and platelet-derived growth factor receptor-a (PDGFRA). The author diag-
nosed the lesion as leiomyosarcoma. After the pathological diagnosis, CT, MRI and PET of the whole body
were performed, but did not reveal any tumors including the uterus. The patient was followed up, and
three years later a recurrent lesion (20 mm in diameter) was identiﬁed in the right upper lobe near the
previous tumor. Biopsy showed leiomyosarcoma with histology and immunohistochemical ﬁndings
similar to the previous tumor. Further operation was impossible because of her medical conditions. She
was treated by chemotherapy and followed up. She was now alive with the small pulmonary tumor,
which shows no rapid growth.
 2009 Elsevier Ltd. All rights reserved.1. Introduction
Primary leiomyosarcomaof the lung is avery rare entity.1–13Most
of the reported cases are large and the origin is obscure,1–8 although
primary leiomyosarcomaswith origin of pulmonaryarteries smooth
muscles9,10 and bronchial smooth muscles11–13 have been reported
in a small number. The lunghas smoothmuscles in the bronchus and
pulmonary vessels; therefore, theoretically, smooth muscle tumors
of the lung may arise from these pulmonary elements (vascular
smooth muscles and bronchial smooth muscles). The author herein
reports a caseof primarysmall (10mmindiameter) leiomyosarcoma
occurring in the periphery of the right upper lobe.
2. Case report
A 74-year-old woman presented with cough and sputum, and
was referred to a private hospital where she was pointed out torved.have an abnormal lung shadow by chest X–P. She was admitted to
our hospital for scrutiny. Imaging modalities including CT and MRI
revealed a small (12 mm in diameter) mass in the periphery of the
right upper lobe. Other tumors were found by whole body CT, MRI,
and PET. It was located just beneath the pleura. Although biopsy
and cytology were negative, video-assisted thoracoscopic wedge
resection was performed with wide surgical margins.
Grossly, the lesion was a round white tumor measuring
10  10  9 mm located beneath the pleura (Figs. 1 and 2).
Microscopically, the tumor was composed of proliferation of
atypical spindle cells with hyperchromatic nuclei (Figs. 3 and 4).
The tumor cells were continuous with bronchial smooth muscle
(Fig. 5). Spatial relationship between the tumor cells and vascular
smooth muscles were not recognized. Mitotic ﬁgures were recog-
nized in 20 per 10 high power ﬁelds (Fig. 4). There were foci of
necrosis and deposition of dusts and hemosiderin (Fig. 3). Residual
bronchi with cartilage and smooth muscles were present within
the tumor (Fig. 6). The tumor cells involved the pleura, and invaded
into the surrounding lung parenchyma (Fig. 2). Zieal–Neelsen stain
did not identify acid-fast bacteria, and Grocott stain did not reveal
fungi.
Fig. 1. Gross ﬁnding. The tumor is cut. The tumor is white and measures 10 mm in
diameter. The pleura is involved by the tumor.
Fig. 3. Very low power view. The tumor consists of proliferation of atypical smooth
muscles. Residual bronchiole, hemorrhage, necrotic areas, and ducts depositions are
recognized. HE, 40.
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Dako’s Envision method (Dako Corp. Glustrup, Denmark), as
previously reported.14,15 The immunohistochemical reagents and
results are shown in Table 1. Immunohistochemically, the tumor
cells were positive for vimentin, (Fig. 7A) a-smooth muscle actin
(Fig. 7B), caldesmon (Fig. 7C), and Ki-67 (labeling ¼ 50%) (Fig. 7D),
but negative for cytokeratins (AE1/3, CAM5.2, KL-1, and polyclonal
wide), cytokeratin 5/6, cytokeratin 7, cytokeratin 20, epithelial
membrane antigen, melanosome, thyroid transcriptional factor-1
(TTF-1), desmin, CD34, calreninin, D2-40 (podoplanin), S100
protein, p53 protein, myoglobin, KIT, and platelet-derived growth
factor receptor-a (PDGFRA).
The author diagnosed the lesion as leiomyosarcoma. After the
pathological diagnosis, CT, MRI and PET of the whole body were
performed, but did not reveal any tumors including the uterus. The
patient was followed up, and three years later a recurrent tumor
(20 mm in diameter) was identiﬁed in the right upper lobe near the
previous tumor by CT. Imaging modalities of whole body CT, MRI,
and PET revealed no tumors other than the pulmonary tumor.
Biopsy showed leiomyosarcoma with the same histology and
immunohistochemical ﬁndings as the previous tumor (Fig. 8).Fig. 2. Loupe features. The tumor is solid one with pleural involvement. Mild degree of
invasion into surrounding lung parenchyma is seen.However, the atypia is more severe compared to the original tumor.
The pathological diagnosis was recurrent leiomyosarcoma. Further
operation was impossible because of her poor medical health
conditions. She was treated by chemotherapy and followed up. She
was now alive with the small pulmonary tumor, which shows no
rapid growth.3. Discussion
The present lung tumor was composed of atypical spindle cells
with hyperchromatic nuclei. Although the atypia is relatively mild,
the high Ki-67 labeling (59%), invasive features, presence of mitosis,
and recurrence indicates that the present tumor is malignant. The
malignant potential of the present tumor appears relatively low,
because the atypia was not severe. In fact, the recurrence occurred
as many as three years later. Therefore, the author considers that
the present tumor is low grade tumor.
The present tumor composed of atypical spindle cells. On HE
sections, exact classiﬁcation was impossible. The immunohisto-
chemical study revealed that the tumor cells were positive forFig. 4. High power of the tumor. The tumor cells are spindle with hyperchromatic
nuclei. The cytoplasm is acidophilic. Mitotic ﬁgures are present. HE, 200.
Fig. 5. The tumor is continuous with bronchial smooth muscle. HE, 40.
Fig. 6. Bronchus with cartilage and smooth muscles is embedded in the tumor.
Hemosiderin is seen. HE, 40.
Table 1
Immunohistochemical reagents and results.
Antigens Antibodies (clone)
Pancytokeratin AE1/3
Pancytokeratin Polyclonal wide
Pancytokeratin KL-1
Pancytokeratin CAM5.2
CK5/6 D5/16
CK7 N1626
CK 20 K20.8
EMA E29
Vimentin Vim 3B4
TTF-1 8G7G3/1
Desmin D33
Myoglobin Polyclonal
S100protein Polyclonal
Melanosome HMB45
ASMA 1A4
Caldesmon h-CD
CD34 NU-4A1
p53protein DO-7
Ki-67 MIB-I
Calrenitin Polyclonal
D2-40 D2-40
KIT Polyclonal
PDGFRA Polyclonal
þþþ, 67–100% positive. þþ, 33–66% positive. þ, 1–33% positive. , negative. CK, cytok
ASMA, a-smooth muscle antigen. PDGFRA, platelet-derived growth factor receptot-a.
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and mesenchymal marker (vimentin). The various types of cyto-
keratins were negative. The ﬁndings indicate that the present
tumor is not a spindle cell carcinoma of the lung but a spindle cell
sarcoma. The positive smooth muscle antigens highly suggest
a leiomyosarcoma. Negative TTF-1 also indicates negative sarco-
matoid adenocarcinomatous nature in the present study. The
negative reactions for melanosome (HMB45) and S100 indicates
that the present tumor is not an amelanotic melanoma. Negative
reactions for calretinin, D2-40 and CK5/6 highly suggest that the
present tumor is not sarcomatoid mesotherioma. This is important
in the present case because the pleura was involved by the tumor
cells. The negative immunoreactions for KIT, PDGFRA, and CD34
indicates that the present tumor is not extra-gastrointestinal
stromal tumor. Other malignant neurogenic, lipogenic and rhab-
domyogenic tumors can be denied because such mesenchymal
markers (S100 protein, desmin, and myoglobin) were negative.
Therefore, the author diagnosed the present case as primary leio-
myosarcoma of the lung.
Most of the reported cases of pulmonary leiomyosarcoma are
relatively large.1–13 The present leiomyosarcoma was very small
(10 mm in diameter). Such small leiomyosarcoma cases were not
reported in the literature. The small size of the present case may
indicate recent advances in imaging techniques.
The present case is primary pulmonary leiomyosarcoma,
because imaging modarities including CT, MRI, and PET revealed no
tumors other than the pulmonary tumor.
The histogenesis of the present case is speculative. Theoretically,
pulmonary leiomyosarcoma arises from vascular smooth
muscles9,10 or bronchial smooth muscles.11–13 The author considers
that the present primary leiomyosarcoma is derived from the
bronchial muscles, because there were merges between the tumor
and bronchial smooth muscles. The presence of bronchus and
bronchioles with cartilages within the tumor also suggests the
bronchial smooth muscle origin.
The present leiomyosarcoma showed unusual features including
dust deposition, hemosiderin deposition, and degenerative features
of tumor cells. The ducts deposition is particularly interesting. At
ﬁrst, it appeared to be dust ﬁbrotic nodule. The ducts in theSources Results
Dako Corp. Glostrup, Denmark 
Dako 
Immunotech, Marseille, France 
Beckton-Dickinson, CA, USA 
Dako 
Dako 
Dako 
Dako 
Dako þþþ
Dako 
Dako 
Dako 
Dako 
Dako 
Dako þþþ
Dako þþþ
Nichirei, Tokyo, Japn 
Dako 
Dako 50%
Invitorogen, Tokyo, Japan 
Signet Lab, Dedham, MA, USA 
Dako 
Santa Cruz, CA, USA 
eratin. TTF-1, thyroid transcriptional factor-1. EMA, epithelial membrane antigen.
Fig. 7. Immunohistochemistry. A: The tumor cells are positive for vimentin (A), a-smooth muscle actin (B), h-caldesmon (C), and Ki-67 (D, Labeling ¼ 50%). A, B, and C: 200.
D: 100.
Fig. 8. Recurrent tumor. The tumor is spindle cell malignancy similar to original tumor.
However, cellular atypia is more severe than that of original tumor. HE, 200.
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ducts within the present tumormay suggest that the tumor arose in
association with lung scar (scar cancer). The hemosiderin deposi-
tion indicates the hemorrhagic nature of the tumor.
The recurrent tumor of the present study showed morphologies
and immunohistochemistry the same as or very similar to the
original tumor. The recurrent tumor is leiomyosarcoma, but it
showed a relatively severe cytological atypia relative to original
tumor, indicating tumor progression.
In summary, the author reported a rare case of primary small
leiomyosarcoma of the lung arising from the bronchial smooth
muscles.Conﬂict of interest
The author has no conﬂict of interests.
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